Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Replication-competent retroviruses in gene-modified T cells used in clinical trials: is it time to revise the testing requirements?

Bear AS, Morgan RA, Cornetta K, June CH, Binder-Scholl G, Dudley ME, Feldman SA, Rosenberg SA, Shurtleff SA, Rooney CM, Heslop HE, Dotti G.

Mol Ther. 2012 Feb;20(2):246-9. doi: 10.1038/mt.2011.288. No abstract available.

2.

Detection of replication competent retrovirus and lentivirus.

Sastry L, Cornetta K.

Methods Mol Biol. 2009;506:243-63. doi: 10.1007/978-1-59745-409-4_17.

PMID:
19110631
3.

A facile method to increase titers of miRNA-encoding retroviruses by inhibition of the RNaseIII enzyme Drosha.

Brandl A, Wittmann J, Jäck HM.

Eur J Immunol. 2011 Feb;41(2):549-51. doi: 10.1002/eji.201040960. Epub 2010 Dec 29. No abstract available.

4.

Gene transfer in avian embryos using replication-competent retroviruses.

Logan C, Francis-West P.

Methods Mol Biol. 1999;97:539-51. No abstract available.

PMID:
10443390
5.

Large-scale manufacturing of safe and efficient retrovirus packaging lines for use in immunotherapy protocols.

Farson D, McGuinness R, Dull T, Limoli K, Lazar R, Jalali S, Reddy S, Pennathur-Das R, Broad D, Finer M.

J Gene Med. 1999 May-Jun;1(3):195-209.

PMID:
10738568
6.

Gene transfer in avian embryos using replication-competent retroviruses.

Logan C, Francis-West P.

Methods Mol Biol. 2008;461:363-76. doi: 10.1007/978-1-60327-483-8_26. Review. No abstract available.

PMID:
19030811
7.

Environmental risk assessment of replication competent viral vectors applied in clinical trials: potential effects of inserted sequences.

van den Akker E, van der Vlugt CJ, Bleijs DA, Bergmans HE.

Curr Gene Ther. 2013 Dec;13(6):395-412. Review.

PMID:
24397527
8.

Delivery of short hairpin RNA sequences by using a replication-competent avian retroviral vector.

Bromberg-White JL, Webb CP, Patacsil VS, Miranti CK, Williams BO, Holmen SL.

J Virol. 2004 May;78(9):4914-6.

9.

Enhanced transduction of antigen-stimulated T lymphocytes with recombinant retroviruses concentrated by centrifugal filtration.

Kinyanjui MW, Ramos-Barbón D, Villeneuve A, Fixman ED.

J Immunol Methods. 2006 Jul 31;314(1-2):80-9. Epub 2006 Jun 30.

PMID:
16842814
10.

Recent developments in retroviral gene delivery systems.

Wysocki PJ, Grabarczyk P, Mackiewicz A.

Expert Opin Biol Ther. 2001 Nov;1(6):911-3.

PMID:
11728224
11.

Biosafety considerations using gamma-retroviral vectors in gene therapy.

Deichmann A, Schmidt M.

Curr Gene Ther. 2013 Dec;13(6):469-77. Review.

PMID:
24195605
12.

Poxviral/retroviral chimeric vectors allow cytoplasmic production of transducing defective retroviral particles.

Holzer GW, Falkner FG.

Methods Mol Med. 2003;76:565-78. No abstract available.

PMID:
12526185
13.

Generation of chimeric T-cell receptor transgenes and their efficient transfer in primary mouse T lymphocytes.

Howland LJ, Haynes NM, Darcy PK.

Methods Mol Biol. 2010;651:291-306. doi: 10.1007/978-1-60761-786-0_17.

PMID:
20686973
14.

Vaccinia viral/retroviral chimeric vectors.

Falkner FG, Holzer GW.

Curr Gene Ther. 2004 Dec;4(4):417-26. Review.

PMID:
15578991
15.

Generation of transduction-competent retroviral vectors by infection with a single hybrid vaccinia virus.

Konetschny C, Holzer GW, Urban C, Hämmerle T, Mayrhofer J, Falkner FG.

J Virol. 2003 Jun;77(12):7017-25.

16.

Efficient transduction and selection of human T-lymphocytes with bicistronic Thy1/HSV1-TK retroviral vector produced by a human packaging cell line.

Lemoine FM, Mesel-Lemoine M, Cherai M, Gallot G, Vié H, Leclercq V, Trébèden-Negre H, Mammès O, Boyer O, Noguiez-Hellin P, Klatzmann D.

J Gene Med. 2004 Apr;6(4):374-86.

PMID:
15079812
17.

Infection of human cells with murine amphotropic replication-competent retroviruses.

Cornetta K, Nguyen N, Morgan RA, Muenchau DD, Hartley JW, Blaese RM, Anderson WF.

Hum Gene Ther. 1993 Oct;4(5):579-88.

PMID:
8280796
18.

Detection of ecotropic replication-competent retroviruses: comparison of s(+)/l(-) and marker rescue assays.

Reeves L, Duffy L, Koop S, Fyffe J, Cornetta K.

Hum Gene Ther. 2002 Sep 20;13(14):1783-90.

PMID:
12396630
19.

Analysis of retroviral packaging lines for generation of replication-competent virus.

Muenchau DD, Freeman SM, Cornetta K, Zwiebel JA, Anderson WF.

Virology. 1990 May;176(1):262-5.

PMID:
2330675
20.

A novel human suspension culture packaging cell line for production of high-titre retroviral vectors.

Chan LM, Coutelle C, Themis M.

Gene Ther. 2001 May;8(9):697-703. Erratum in: Gene Ther 2001 Oct;8(19):1514.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk